BridgeBio Oncology Therapeutics Inc.
BBOT | NASDAQ
$4.70
+$0.04 (+0.86%)
Sep 22, 2026, 10:52 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q4 2022 Dec 30, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 186K | n/a | n/a | n/a | n/a | n/a | 156K | n/a | n/a | n/a | n/a |
Gross Profit | n/a | -186K | n/a | n/a | n/a | n/a | n/a | -156K | n/a | n/a | n/a | n/a |
Operating Income | -60.19M | -46.18M | -43.41M | -49.18M | -30.09M | -23.14M | -21.88M | -19.66M | -23.87M | -15.45M | -41.69K | -3.52K |
Interest Income | 3.55M | 3.94M | 4.42M | 3.44M | 2.08M | 1.81M | 2.25M | 2.56M | 2.44M | 1.21M | n/a | n/a |
Pretax Income | -56.45M | -42.11M | -38.8M | -44.76M | -28.44M | -22.06M | -19.69M | -17.32M | -21.82M | -15.44M | -41.69K | -3.52K |
Net Income | -56.45M | -42.11M | -38.8M | -44.76M | -28.44M | -22.06M | -19.69M | -17.32M | -21.82M | -15.44M | -41.69K | -3.52K |
Selling & General & Admin | 10.96M | 6.38M | 5.33M | 14.13M | 2.66M | 2.5M | 2.34M | 1.78M | 1.36M | 2.28M | 41.69K | 3.52K |
Research & Development | 49.23M | 39.8M | 38.07M | 35.05M | 27.44M | 20.64M | 19.54M | 17.89M | 22.51M | 13.17M | n/a | n/a |
Other Expenses | n/a | -186K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 41.69K | n/a |
Operating Expenses | 60.19M | 45.99M | 43.41M | 49.18M | 30.09M | 23.14M | 21.88M | 19.66M | 23.87M | 15.45M | 41.69K | 3.52K |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 60.19M | 46.18M | 43.41M | 49.18M | 30.09M | 23.14M | 21.88M | 19.66M | 23.87M | 15.45M | 41.69K | 3.52K |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 80.05K | 31.14M | 31.14M | 23.51M | 23.51M | 23.51M | 16.64M | 23.51M | 23.51M | 22M | 20.49M | 20.49M |
Shares Outstanding (Diluted) | 80.05K | 31.14M | 31.14M | 23.51M | 23.51M | 23.51M | 16.64M | 23.51M | 23.51M | 22M | 20.49M | 20.49M |
EPS (Basic) | -705.20 | -1.35 | -1.25 | -1.90 | -1.21 | -0.94 | 0.12 | -0.74 | 0.09 | 0.05 | 0 | 0 |
EPS (Diluted) | -705.20 | -1.35 | -1.25 | -1.90 | -1.21 | -0.94 | 0.12 | -0.74 | 0.09 | 0.05 | 0 | 0 |
EBITDA | -56.45M | -45.99M | -43.21M | -49M | -29.91M | -23.08M | -21.83M | -19.61M | -23.82M | -15.4M | -41.69K | -3.52K |
EBIT | -56.45M | -46.18M | -43.41M | -49.18M | -30.09M | -23.14M | -21.88M | -19.66M | -23.87M | -15.45M | -41.69K | -3.52K |
Depreciation & Amortization | n/a | 186K | 194K | 181K | 181K | 54K | 52K | 52K | 52K | 52K | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove BBOT